Human ATG9B/APG9L2/ NOS3AS ORF/cDNA clone-Lentivirus particle (NM_001317056.1)
Pre-made Human ATG9B/APG9L2/ NOS3AS Lentiviral expression plasmid for ATG9B lentivirus packaging, ATG9B lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go
to ATG9B/APG9L2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMAP-atg-068 | Human ATG9B Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMAP-atg-068 |
Gene Name | ATG9B |
Accession Number | NM_001317056.1 |
Gene ID | 285973 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 2775 bp |
Gene Alias | APG9L2, NOS3AS, SONE |
Fluorescent Reporter | EGFP |
Mammalian Cell Selection | |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
Sequence | ATGGTGAGCCGAATGGGCTGGGGGGGGAGAAGAAGGCGGCTGGGGCGGTGGGGAGATCTGGGGCCCGGATCGGTGCCCCTCCTCCCCATGCCACTGCCACCTCCTCCTCCTCCTTCATGCCGGGGACCTGGGGGAGGGAGGATCTCCATCTTCTCTCTGTCCCCTGCCCCTCATACAAGAAGCTCCCCCTCCTCATTTTCCCCTCCCACCGCAGGGCCCCCTTGCTCAGTGCTACAGGGGACAGGGGCTTCTCAGTCTTGCCACAGTGCTCTCCCTATCCCAGCCACCCCCCCAACACAGGCTCAACCTGCAATGACACCTGCCTCTGCATCTCCCTCCTGGGGATCCCACTCCACCCCACCCCTGGCCCCGGCAACCCCCACTCCCTCACAGCAGTGCCCCCAGGACTCTCCTGGGCTGCGGGTAGGCCCTTTGATCCCTGAACAGGATTATGAGCGGCTGGAGGACTGTGACCCTGAGGGGTCCCAAGACTCACCCATCCACGGGGAGGAGCAGCAACCCCTGCTTCATGTCCCTGAAGGGCTCCGAGGCTCCTGGCATCACATCCAGAACCTGGACAGTTTCTTCACCAAGATCTACAGCTACCACCAGCGGAATGGCTTTGCCTGCATCTTGCTGGAGGATGTCTTCCAGCTGGGACAATTTATTTTCATTGTCACCTTCACAACCTTCCTCCTTCGATGCGTGGATTACAATGTTCTCTTTGCCAACCAACCAAGTAACCATACCAGACCTGGGCCGTTCCACAGCAAAGTGACCCTGTCAGATGCCATCCTACCCTCAGCCCAGTGTGCTGAGAGGATCCGCTCCAGCCCGCTGCTGGTCCTCCTCCTGGTCCTGGCTGCCGGCTTCTGGCTGGTCCAACTGCTTCGCTCAGTCTGCAACCTCTTCAGCTACTGGGACATCCAGGTGTTTTACAGGGAGGCCCTGCACATCCCCCCGGAGGAGCTGAGCTCGGTTCCCTGGGCAGAGGTGCAGTCCCGCCTCTTGGCACTGCAGCGGAGCGGGGGCCTGTGCGTGCAGCCGCGGCCCCTGACGGAGCTGGACATCCACCACCGCATCCTGCGCTACACCAACTACCAGGTGGCGCTGGCCAACAAAGGCCTGCTGCCGGCCCGCTGCCCGCTGCCCTGGGGAGGCAGTGCGGCTTTCCTCAGCCGCGGCCTGGCGCTCAATGTCGACCTGCTGCTCTTCCGCGGTCCCTTCTCGCTCTTCCGCGGGGGCTGGGAGCTGCCGCACGCCTACAAGCGCAGCGACCAGCGGGGCGCCCTAGCAGCGCGCTGGGGGCGCACAGTGCTGCTGCTGGCCGCCCTGAACCTGGCGCTGAGCCCGCTGGTGCTGGCCTGGCAGGTTCTGCACGTCTTCTATAGCCACGTGGAGCTGCTGCGGCGCGAGCCTGGCGCGCTGGGGGCGCGCGGCTGGTCCCGCCTGGCGCGCTTGCAGCTGCGCCACTTCAACGAGCTGCCGCACGAGCTGCGCGCGCGCCTGGCCCGCGCCTACCGCCCCGCCGCCGCCTTCCTGCGCACCGCTGCGCCCCCCGCGCCCCTGCGCACGCTGCTGGCCCGCCAGCTCGTTTTCTTCGCGGGTGCACTCTTCGCCGCGCTGCTTGTGCTCACCGTCTACGACGAGGACGTGCTAGCCGTGGAGCACGTGCTCACCGCCATGACCGCGCTCGGGGTCACCGCCACCGTCGCCAGGTCTTTCATTCCGGAAGAGCAGTGCCAGGGTCGTGCGCCGCAGCTCCTGCTGCAGACAGCCCTGGCCCACATGCACTACCTCCCGGAGGAGCCCGGCCCCGGCGGCAGGGACCGCGCCTACCGGCAGATGGCGCAGCTGCTGCAGTACCGAGCGGTCTCCCTCCTGGAGGAGCTCCTGTCCCCGCTCCTCACCCCGCTGTTTCTGCTTTTCTGGTTCCGCCCTCGTGCCCTGGAGATTATCGACTTTTTTCATCACTTCACTGTGGATGTGGCTGGGGTTGGGGACATCTGTTCCTTTGCCCTTATGGATGTGAAGCGCCACGGACACCCTCAGTGGCTCTCGGCGGGACAGACTGAGGCCTCGCTGTCTCAGCGTGCGGAGGACGGCAAGACTGAGCTTTCTTTGATGCGGTTCTCCCTGGCGCATCCACTCTGGCGCCCCCCAGGGCACAGCTCTAAGTTTCTTGGGCACCTCTGGGGCCGAGTACAACAAGATGCAGCTGCCTGGGGTGCCACCTCGGCTCGCGGCCCCTCCACCCCGGGGGTGCTCAGCAACTGCACCTCGCCCCTGCCTGAGGCCTTCCTGGCCAACCTCTTCGTGCACCCTCTCCTGCCTCCGAGAGATCTGAGCCCGACAGCCCCCTGTCCAGCTGCGGCCACAGCCAGCCTCCTTGCCTCCATTTCCCGAATTGCCCAGGACCCCAGCTCTGTGTCCCCAGGAGGCACTGGGGGCCAGAAGCTGGCCCAGCTCCCAGAACTTGCTTCTGCCGAGATGAGTCTCCATGTCATCTACCTGCACCAGCTTCACCAGCAGCAGCAGCAGCAGGAGCCGTGGGGTGAGGCTGCAGCCTCCATCCTGTCCAGGCCCTGCTCCAGCCCCTCACAGCCACCCTCGCCTGATGAGGAGAAGCCATCCTGGTCAAGTGACGGCTCCAGTCCTGCCTCTAGCCCCAGACAACAGTGGGGAACCCAGAAGGCCCGGAATCTGTTCCCCGGAGGGTTTCAGGTGACCACAGACACCCAGAAGGAGCCTGACCGGGCCTCTTGCACTGACTGA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-IP0379-Ab | Anti-ATG9B monoclonal antibody |
Target Antigen | GM-Tg-g-IP0379-Ag | ATG9B protein |
ORF Viral Vector | pGMLV000336 | Human ATG9B Lentivirus plasmid |
ORF Viral Vector | pGMLV000490 | Human ATG9B Lentivirus plasmid |
ORF Viral Vector | pGMLP-atg-014 | Human ATG9B Lentivirus plasmid |
ORF Viral Vector | pGMAP-atg-068 | Human ATG9B Lentivirus plasmid |
ORF Viral Vector | vGMLV000336 | Human ATG9B Lentivirus particle |
ORF Viral Vector | vGMLV000490 | Human ATG9B Lentivirus particle |
ORF Viral Vector | vGMLP-atg-014 | Human ATG9B Lentivirus particle |
ORF Viral Vector | vGMAP-atg-068 | Human ATG9B Lentivirus particle |
Target information
Target ID | GM-IP0379 |
Target Name | ATG9B |
Gene ID | 285973, 213948, 714284, 499973, 101096716, 482799, 506862, 100064027 |
Gene Symbol and Synonyms | Apg912,APG9L2,Apgdc2,ATG9B,eONE,Gm574,NOS3AS,RGD1560887,SONE |
Uniprot Accession | Q674R7 |
Uniprot Entry Name | ATG9B_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Not Available |
Disease | Not Available |
Gene Ensembl | ENSG00000181652 |
Target Classification | Not Available |
This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand. Mutations in this gene and disruption of the autophagy process have been associated with multiple cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.